Survivin selective inhibitor YM155 promotes cisplatin-induced apoptosis in embryonal rhabdomyosarcoma

上野, 豪久

Number of Access:666（2025-07-22 22:06 Counts）

Identifier to cite or link to this item: https://hdl.handle.net/11094/59545

Link to primary information 

File Format Terms of use Size Views Date.Available Description information
28609_Abstract pdf None 133 KB 113 2017.01.19  

Item Information

Output File Export EndNote Basic Export Mendeley

Title
Survivin selective inhibitor YM155 promotes cisplatin-induced apoptosis in embryonal rhabdomyosarcoma
サバイビン選択阻害剤YM155は胎児型横紋筋肉腫のシスプラチン依存アポトーシスを促進する
サバイビンセンタクソガイザイYM155ハタイジガタオウモンキンニクシュノシスプラチンイゾンアポトーシスヲソクシンスル
Creator
NRID
1000010456957 1000010456957
ORCID
0000-0002-4639-8814 0000-0002-4639-8814
researchmap permalink
ueno-pedsurg ueno-pedsurg
Scopus Author ID
21743992300 21743992300
CreatorName
上野, 豪久 ; ウエノ, タケヒサ
Degree Name
博士（医学）
Date of Granted
2016-08-22
Grantor
Osaka University
Faculty
医学系
Grant ID
乙第09920号
Description Number
28609
Language
English
Handle URL
https://hdl.handle.net/11094/59545
Access Rights
open access
Category
Doctoral Thesis / Graduate School of Medicine / 2016
Note
やむを得ない事由があると学位審査研究科が承認したため、全文に代えてその内容の要約を公開しています。全文のご利用をご希望の場合は、大阪大学の博士論文についてをご参照ください。
Only the abstract of the doctoral thesis, instead of the full text, is available due to an unavoidable reason which was accepted by the degree-awarding graduate school. If you would like to read the full text, please refer to Doctoral Theses of Osaka University.